Activity

#4 in a series of five articles on the use of medical cannabis as a peripheral neuropathy treatment. Includes legalization, use, benefits and effects

Neuropathic pain is a chronic condition that affects an estimated 6.9-10.0% of people and usually arises from damage to the nervous system. The mechanisms underlying neuropathic pain are complex an…

Neuropathic pain is a chronic illness affecting 7-10 percent of the population in France and for which there is no effective treatment. Researchers have uncovered the mechanism behind the appearance and continuation of pain. Based on their discovery, an innovative treatment was developed which produces, in animal subjects, an immediate, robust and long-lasting therapeutic effect on pain symptoms.

It is common for people with peripheral neuropathy to experience different degrees of pain. It’s important to identify the type of pain medication that will work best for managing painful peripheral neuropathy symptoms, that also works with your body chemistry, and compliments other treatments.

Thirty percent of all Americans will be affected by peripheral neuropathy, a condition that impacts nerves leading to the arms and legs.

Peripheral neuropathy affects the peripheral nervous system, which transmits messages between the central nervous system and other parts of the body.

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term peripheral neuropathy, leaving little data for patients and clinicians to make informed decisions.

Painful nerve damage is common in diabetes but poorly understood. Now, a new study shows that blocking the molecule HCN2 may provide effective pain relief.